Crescita Therapeutics, Inc.
OTC: CRRTF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Serge Verreault
- Employees
- 65
- Headquarters
- Laval, Canada
- IPO year
- 2016
- Market cap
- $10.4M
- Website
- https://www.crescitatherapeutics.com
Loading CRRTF…
Loading profile data…Frequently asked questions about CRRTF
What does Crescita Therapeutics, Inc. (CRRTF) do?
Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. It operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The company owns proprietary platform technologies, incl...
Where does CRRTF trade?
Crescita Therapeutics, Inc. (CRRTF) trades on the Other OTC.
What sector is CRRTF in?
Crescita Therapeutics, Inc. (CRRTF) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Crescita Therapeutics, Inc.?
Serge Verreault is the chief executive officer of Crescita Therapeutics, Inc. (CRRTF).
Where is Crescita Therapeutics, Inc. headquartered?
Crescita Therapeutics, Inc. is headquartered in Canada.
Does CRRTF pay a dividend?
Crescita Therapeutics, Inc. (CRRTF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CRRTF go public?
Crescita Therapeutics, Inc. (CRRTF) completed its initial public offering in 2016.